ZA93652B - Tetrahydropyrimidine derivatives and pharmaceutical compositions containing them. - Google Patents

Tetrahydropyrimidine derivatives and pharmaceutical compositions containing them.

Info

Publication number
ZA93652B
ZA93652B ZA93652A ZA93652A ZA93652B ZA 93652 B ZA93652 B ZA 93652B ZA 93652 A ZA93652 A ZA 93652A ZA 93652 A ZA93652 A ZA 93652A ZA 93652 B ZA93652 B ZA 93652B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical compositions
compositions containing
tetrahydropyrimidine derivatives
tetrahydropyrimidine
derivatives
Prior art date
Application number
ZA93652A
Inventor
Aviva Lapidot
Livia Inbar
Yosef Aloni
Edna Ben-Asher
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of ZA93652B publication Critical patent/ZA93652B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom
    • C12P17/12—Nitrogen as only ring hetero atom containing a six-membered hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

The present invention relates to purified tetrahydropyrimidine derivatives and to pharmaceutical compositions comprising them. The tetrahydropyrimidine derivatives are useful for DNA protection from damaging by DNA-binding drugs, chemical carcinogens and mutagens and from irradiation.
ZA93652A 1992-01-30 1993-01-29 Tetrahydropyrimidine derivatives and pharmaceutical compositions containing them. ZA93652B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL10081092A IL100810A (en) 1992-01-30 1992-01-30 Pharmaceutical compositions comprising 2-methyl-4-carboxy-5-hydroxy-tetrahydropyrimidine and/or 2-methyl-4-carboxy-tetrahydropyrimidine methods for the isolation and purification of said compounds and substantially pure 2-methyl-4-carboxy-5-hydroxy-3, 4, 5, 6-tetrahydropyrimidine salts 5-ethers and 5-esters thereof

Publications (1)

Publication Number Publication Date
ZA93652B true ZA93652B (en) 1993-09-02

Family

ID=11063323

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA93652A ZA93652B (en) 1992-01-30 1993-01-29 Tetrahydropyrimidine derivatives and pharmaceutical compositions containing them.

Country Status (12)

Country Link
US (1) US5789414A (en)
EP (2) EP0553884B1 (en)
JP (1) JPH0717864A (en)
CN (1) CN1080172A (en)
AT (1) ATE169339T1 (en)
AU (1) AU3213993A (en)
CA (1) CA2088390A1 (en)
DE (1) DE69320075T2 (en)
HU (1) HUT67711A (en)
IL (1) IL100810A (en)
NZ (1) NZ245797A (en)
ZA (1) ZA93652B (en)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4244580A1 (en) * 1992-12-31 1994-07-07 Galinski Erwin A Process for the in vivo extraction of ingredients from cells
DE4342560A1 (en) * 1993-12-14 1995-06-22 Marbert Gmbh Use of 1,4,5,6-tetra:hydro-4-pyrimidine carboxylic acid derivs. in cosmetics
DE19711082A1 (en) * 1997-03-18 1998-09-24 Degussa Process for the separation of tetrahydropyrimidines from aqueous solutions
IL123256A0 (en) 1998-02-10 1998-09-24 Yeda Res & Dev Methods for dna amplification and sequencing
DE19821378A1 (en) * 1998-05-13 1999-11-18 Degussa Process for the separation of tetrahydropyrimidine derivatives
DE19834816A1 (en) * 1998-08-01 2000-02-03 Merck Patent Gmbh Use of ectoin or ectoin derivatives in cosmetic formulations
US20030157040A1 (en) * 1998-08-01 2003-08-21 Merck Patent Gmbh Use of ectoine or ectoine derivatives in cosmetic formulations
US20040047828A1 (en) * 1998-08-01 2004-03-11 Merck Patent Gmbh Ectoin or ection derivatives and surfactants
EP1183047B1 (en) * 1999-06-12 2003-08-27 bitop Aktiengesellschaft für biotechnische Optimierung Pharmaceutical preparation
DE19957470A1 (en) * 1999-11-24 2001-06-21 Actinodrug Pharmaceuticals Gmb Tetrahydropyrimidine dioxygenase gene and method for enzymatic in vivo and in vitro production of hydroxylated tetrahydropyrimidines
DE10002725A1 (en) * 2000-01-11 2001-07-12 Beiersdorf Ag Treatment and prevention of undesired skin pigmentation, e.g. to prevent tanning or to remove freckles, using an ectoin compound, especially ectoin or hydroxyectoin
DE10043456A1 (en) * 2000-09-04 2002-03-14 Merck Patent Gmbh Use of ectoin or ectoin derivatives to stabilize p53
US7048910B2 (en) * 2000-09-07 2006-05-23 Merck Patent Gmbh Use of ectoine or ectoine derivatives for oral care
DE10047444A1 (en) * 2000-09-21 2002-04-11 Bitop Gmbh Process for the separation and high-purity isolation of low-molecular, structurally similar compounds, in particular of tetrahydropyrimidine derivatives such as e.g. 1,4,5,6-tetrahydro-2-methyl-4-pyrimidinecarboxylic acids (ectoins) and their cleavage products
DE10214257A1 (en) * 2002-03-28 2003-10-16 Merck Patent Gmbh Use of compatible solutes to inhibit the release of ceramides
RU2418633C2 (en) * 2004-04-08 2011-05-20 Байоматрика, Инк. Integration of specimens storage and control in biomedical sciences
EP1858519B1 (en) * 2005-03-12 2013-02-20 Bitop Aktiengesellschaft Für Biotechnische Optimierung Ectoin and/or hydroxyectoin for the prevention and treatment of inflammatory bowel diseases
FR2896990B1 (en) * 2006-02-03 2008-05-02 Lvmh Rech PROTECTIVE AND REGENERATIVE COMPOSITION
DE102007052380A1 (en) * 2007-10-31 2009-05-07 Bitop Ag Osmolyte-containing preparations for use in dry mucous membranes
ES2700613T3 (en) * 2008-07-16 2019-02-18 Bitop Ag Synthesis of cyclic amidines
DE102008039231A1 (en) 2008-08-22 2010-02-25 Bitop Ag Use of glucosylglycerol
EP2168570B1 (en) 2008-09-30 2013-12-25 Symrise AG Extracts of isochrysis sp.
EP3348255B1 (en) 2008-12-05 2021-11-10 Symrise AG Extracts of tetraselmis sp. for cosmetic and therapeutic purposes
US8519125B2 (en) * 2009-05-11 2013-08-27 Biomatrica, Inc. Compositions and methods for biological sample storage
US8774488B2 (en) 2010-03-11 2014-07-08 Cellscape Corporation Method and device for identification of nucleated red blood cells from a maternal blood sample
US9845489B2 (en) 2010-07-26 2017-12-19 Biomatrica, Inc. Compositions for stabilizing DNA, RNA and proteins in saliva and other biological samples during shipping and storage at ambient temperatures
WO2012018638A2 (en) 2010-07-26 2012-02-09 Biomatrica, Inc. Compositions for stabilizing dna, rna and proteins in blood and other biological samples during shipping and storage at ambient temperatures
CN102225067B (en) * 2011-04-29 2012-10-03 济南环肽医药科技有限公司 Pharmaceutical composition for treating stomach cancer
CN102240298B (en) * 2011-04-29 2012-07-04 济南环肽医药科技有限公司 Pharmaceutical composition for resisting tumors
CN102258526B (en) * 2011-04-29 2012-10-31 山东大学 Anticancer medicinal composition
CN102210868A (en) * 2011-04-29 2011-10-12 济南环肽医药科技有限公司 Application of tetrahydropyrimidine and derivatives thereof in preparing oral absorption enhancers
CN102617707B (en) * 2011-09-19 2014-01-29 江苏师范大学 Preparation method of new homologue 2-methyl-actinomycin D of actinomycin D
EP2934572A4 (en) 2012-12-20 2016-11-23 Biomatrica Inc Formulations and methods for stabilizing pcr reagents
ES2701758T3 (en) 2013-02-27 2019-02-25 Symrise Ag Ginger extract for the protection of stem cells
EP2862852B1 (en) 2013-10-18 2018-07-04 Symrise AG Urea derivatives for the protection of stem cells
EP2921157B1 (en) 2014-03-18 2017-08-16 Symrise AG Coated titanium dioxide to reduce whitening effect on skin
ES2819207T3 (en) 2014-04-29 2021-04-15 Symrise Ag Active mixes
EP3154338B1 (en) 2014-06-10 2020-01-29 Biomatrica, INC. Stabilization of thrombocytes at ambient temperatures
EP3045161A1 (en) 2015-01-18 2016-07-20 Symrise AG Active compositions comprising 1,2-hexanediol and 1,2-octanediol
EP4242628A3 (en) 2015-12-08 2023-11-08 Biomatrica, INC. Reduction of erythrocyte sedimentation rate
CN105669560B (en) * 2016-01-12 2019-02-19 天津科技大学 A method of the separation and Extraction tetrahydropyrimidine from fermentation liquid
CN106361764A (en) * 2016-08-29 2017-02-01 沂水县人民医院 Liver cancer surgical incision flushing liquid
CN109053587A (en) * 2018-08-31 2018-12-21 山东福田药业有限公司 A method of the separation and Extraction tetrahydropyrimidine from halophilic microorganism fermentation liquid
CN110982843B (en) * 2019-10-31 2021-12-28 温州大学 Application of tetrahydropyrimidine in regulating DNA (deoxyribonucleic acid) coagulation strength

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4261995A (en) * 1979-08-31 1981-04-14 Syntex (U.S.A.) Inc. 4-Phenyl-and 5-phenyl-1,4,5,6-tetrahydropyrimidine derivatives

Also Published As

Publication number Publication date
NZ245797A (en) 1995-07-26
CA2088390A1 (en) 1993-07-31
AU3213993A (en) 1993-08-05
DE69320075T2 (en) 1999-04-22
HUT67711A (en) 1995-04-28
ATE169339T1 (en) 1998-08-15
DE69320075D1 (en) 1998-09-10
IL100810A0 (en) 1992-09-06
EP0553884B1 (en) 1998-08-05
US5789414A (en) 1998-08-04
CN1080172A (en) 1994-01-05
JPH0717864A (en) 1995-01-20
HU9300251D0 (en) 1993-04-28
EP0845539A1 (en) 1998-06-03
EP0553884A1 (en) 1993-08-04
IL100810A (en) 1996-12-05

Similar Documents

Publication Publication Date Title
ZA93652B (en) Tetrahydropyrimidine derivatives and pharmaceutical compositions containing them.
IL105715A0 (en) 7beta substituted-4-aza-5alpha-androstan-3-ones and pharmaceutical compositions containing them
PH31294A (en) Benzimidazolyl derivatives, pharmaceutical compositions containing these compounds and process for preparing them.
FR2680507B1 (en) NOVEL NAPHTYLETHYLUREES AND NAPHTYLETHYLTHIOURES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
ZA915717B (en) Benzimidazoles,pharmaceutical compositions containing these compounds and processes for preparing them
IL105717A0 (en) 7beta substituted-4-aza-5alpha-cholestan-3-ones and pharmaceutical compositions containing them
UA32543C2 (en) Aryl acetamides having analgetic action, a PROCESS for preparation thereof, pharmaceutical composition and a PROCESS for preparation thereof
PL337499A1 (en) Novel 2-(iminomethyl)aminophenylic derivatives, their production and application as drugs and pharmaceutic agents containing such derivatives
HUT70150A (en) Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridines, pharmaceutical compositions containing them and method for its preparation
WO1992014696A3 (en) SUBSTITUTED α-AMINOALDEHYDES AND DERIVATIVES
IL113103A0 (en) Piperidine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
IL101358A0 (en) Crystalline tiagabine hydrochloride monohydrate,its preparation and pharmaceutical compositions containing it
IL105348A0 (en) Azabicyclo derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
KR950700310A (en) Heterotricyclic derivatives, methods for their preparation and pharmaceutical compositions containing them (HETEROTRICYCLIC DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM)
IL107358A0 (en) a-Phosphonosulfonate derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same
HUP0004588A3 (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-oles, method for the production and use thereof as medicaments and pharmaceutical compositions containing them
ZA911804B (en) 1-azabicyclic compounds,processes and pharmaceutical compositions containing them
EP0572308A3 (en) Heterocyclic derivatives, process for their preparation and pharmaceutical compositions containing them.
ZA931593B (en) 2,4-Thiazolidinedione compounds, process for preparing them and pharmaceutical compositions containing them.
DK0577745T3 (en) Bis-naphthalimides containing amide and thioamide compounds as anticancer agents.
IL107808A0 (en) Diarylalkane derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same
TW218011B (en)
FR2704857B1 (en) New substituted benzodioxins, process for their preparation and pharmaceutical compositions containing them.
HU9402854D0 (en) Pharmaceutical compositions containing quinoline-3-carboxamide compounds
IL106289A (en) Phospholipid derivatives their preparation and pharmaceutical compositions containing them